KERSTEN GEERT R
Transaction: 08/14/2026
BUY
Change
+300,000
Price
$1.49
Filing
08/17/2026
Type
BUY
CEL-SCI Corporation
CVM • Biotechnology
$1.65
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$19.99M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.59Healthy liquidity · 2.26Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 18, 2026, 3:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.65
Change0.00%
Shares Out12.12M
Market Cap$19.99M
Enterprise Value$1.39B
52W Range0.89 - 13.48
Beta0.56
P/E-1.17
P/B0.00
P/FCF-1.19
EV/EBITDA-100.68
EV/FCF-83.07
Price$1.65
Change0.00%
Shares Out12.12M
Market Cap$19.99M
Enterprise Value$1.39B
52W Range0.89 - 13.48
Beta0.56
P/E-1.17
P/B0.00
P/FCF-1.19
EV/EBITDA-100.68
EV/FCF-83.07
Earnings Yield-85.21%
FCF Yield-83.79%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.59
Current Ratio2.26
Quick Ratio2.20
Revenue 5Y-100.00%
Volume29.40K
Avg Volume425.19K
EPS Surprise0.30
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Manageable debt level · 0.59Healthy liquidity · 2.26Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-10-20
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
PRICHEP PATRICIA B
Transaction: 08/14/2026
BUY
Change
+225,000
Price
$1.49
Filing
08/17/2026
Type
BUY
TALOR EYAL
Transaction: 08/14/2026
BUY
Change
+250,000
Price
$1.49
Filing
08/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| KERSTEN GEERT R | BUY | +300,000 | $1.49 | 08/14/2026 | 08/17/2026 |
| PRICHEP PATRICIA B | BUY | +225,000 | $1.49 | 08/14/2026 | 08/17/2026 |
| TALOR EYAL | BUY | +250,000 | $1.49 | 08/14/2026 | 08/17/2026 |
| CIPRIANO JOHN | BUY | +80,000 | $1.49 | 08/14/2026 | 08/17/2026 |
| BAILLAVOINE BRUNO JEAN-MARIE | BUY | +110,000 | $1.49 | 08/14/2026 | 08/17/2026 |
| Watson Robert Eugene | BUY | +110,000 | $1.49 | 08/14/2026 | 08/17/2026 |
| KERSTEN GEERT R | BUY | +5,192 | $1.04 | 06/30/2026 | 07/01/2026 |
| PRICHEP PATRICIA B | BUY | +4,125 | $1.04 | 06/30/2026 | 07/01/2026 |
| TALOR EYAL | BUY | +2,307 | $1.04 | 06/30/2026 | 07/01/2026 |
| KERSTEN GEERT R | BUY | +300,000 | $1.20 | 05/14/2026 | 05/18/2026 |
| KERSTEN GEERT R | BUY | +100,000 | $1.19 | 05/13/2026 | 05/14/2026 |
| KERSTEN GEERT R | BUY | +1,682 | $3.21 | 03/31/2026 | 04/01/2026 |
| PRICHEP PATRICIA B | BUY | +1,336 | $3.21 | 03/31/2026 | 04/01/2026 |
| TALOR EYAL | BUY | +747 | $3.21 | 03/31/2026 | 04/01/2026 |
| KERSTEN GEERT R | BUY | +38,023 | $5.26 | 01/22/2026 | 01/26/2026 |
| KERSTEN GEERT R | BUY | +998 | $5.26 | 12/31/2025 | 01/05/2026 |
| PRICHEP PATRICIA B | BUY | +815 | $5.26 | 12/31/2025 | 01/05/2026 |
| TALOR EYAL | BUY | +456 | $5.26 | 12/31/2025 | 01/05/2026 |
| KERSTEN GEERT R | BUY | +8,389 | $5.96 | 12/04/2025 | 12/05/2025 |
| KERSTEN GEERT R | BUY | +570 | $9.20 | 09/30/2025 | 10/02/2025 |